Last update:

Oncology & Cancer news

Oncology & Cancer

Study finds common breast cancer treatments may speed aging process

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological aging ...

Oncology & Cancer

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

Oncology & Cancer

Study explores novel therapeutic treatment for glioblastoma

Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments, the two-year survival rate for GBM patients is ...

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Oncology & Cancer

Colonoscopies among the young are on the rise

Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommended.

Oncology & Cancer

Is there a connection between ultraprocessed food and cancer?

There is a growing body of evidence that shows ultraprocessed foods are not only unhealthy but increase the risk of cancers. The term ultraprocessed food was created as a way to categorize food, known as the NOVA classification. ...

Oncology & Cancer

Trial shows promise for new antibody cancer treatment

The first ever clinical trial of a new class of immunotherapy for cancer has shown promising results that could benefit patients who do not respond to existing cancer treatments.

Oncology & Cancer

Origins of glioma brain cancer found to be in the epigenome

While cancers often originate from mutations and other alterations of cells' DNA, researchers in the Bernstein Laboratory at Dana-Farber and the Broad Institute of MIT and Harvard have found that gliomas—incurable brain ...

Oncology & Cancer

Enhancing quality of life for brain tumor survivors

Every day in Australia, six people are diagnosed with a brain tumor and four will die, making services to enhance quality of life for individuals and their families imperative.

Oncology & Cancer

Calling for cancer centers to lead on climate disaster preparedness

Cancer centers are uniquely positioned to protect communities and their most vulnerable residents—cancer patients—from climate-driven disasters by bolstering emergency preparedness, noted researchers with Sylvester Comprehensive ...

Oncology & Cancer

Cellular 'fingerprint' may offer early warning of cancer risk

For nearly every disease, age is a major risk factor, and cancer is no exception. Between the ages of 25 and 65, an individual's risk of developing cancer skyrockets by 4,000%. A new study explores a "fingerprint" in cells ...

Oncology & Cancer

Researchers identify link between cancer-causing gene and aging

A gene called Myc (pronounced "mick") that is among the most important drivers of cancer in both mice and humans also plays a newly discovered crucial role in aging, according to a new Cell Reports study by researchers at ...

Oncology & Cancer

Aging and cancer hallmarks as therapeutic targets

The prevalence of age-related diseases has been progressively increasing worldwide. The pathogenesis of these disorders, including cancer, is closely associated with an age-dependent decline in cellular functions. There are ...